We are pleased to announce The Max Foundation CEO and co-founder, Pat Garcia-Gonzalez, has been nominated as one of three finalists for the Outstanding Contribution to Cancer Control Award, by UICC. We are honored to see The Max Foundation’s efforts recognized by the UICC.
Pat Garcia-Gonzalez shared her gratitude, saying, “This nomination means the world to me and to all whose voices we represent. At The Max Foundation we believe that all people should be able to access the treatment they need, geography should not be destiny, and everyone should be able to strive for health with dignity and hope.
In the past 20 years we have demonstrated that it is possible to safely treat many cancers in low- and middle-income countries. Now we can prevent unnecessary suffering and premature death and because we can, we must.”
Pat is nominated in the civil society category, alongside Paul Farmer, Co-Founder and Chief Strategist, Partners in Health, and Maira Caleffi, breast surgeon and founder of FEMAMA. UICC has also nominated President Joe Biden, Minister Greg Hunt, and President Paul Kagame in the policy-makers category.
The panel of judges for UICC’s Outstanding Contribution to Cancer Control Awards includes: the members of the Board of the Union for International Cancer Control (UICC); the Editors in Chief of the three following scientific journals: Lancet Oncology, International Journal of Cancer, Journal of Global Oncology; and the CEO of the American Society for Clinical Pathology.
The Awards Ceremony will take place October 26th at the 2021 World Cancer Leaders’ Summit in Boston.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Tanner Pharma Group will serve as the title sponsor for The Max Foundation’s 2018 campaign “Max Global Experience: Uganda,” an expedition to raise awareness and funds for increased cancer treatment access in Africa.
Graciela Mabel Woloj Rothstein and Mikkel Z. Oestergaard, PhD join the board this March
Agreement to provide Verzenio® (abemaciclib) free of charge to patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) Lilly joins ongoing effort of Humanitarian Partnership for Access to Critical Treatment (Humanitarian PACT) to eliminate healthcare disparities for patients living with advanced breast cancer in low- and middle-income countries….
